News

EpiPen 300µg recall

recall regulatory
Alphapharm is recalling several batches of EpiPen 300µg, with an expiry date of April 17 Following consultation with the TGA, Alphapharm has initiated a recall of four batches of its EpiPen 300 microgram (µg) Adrenaline Injection Syringe Auto-Injectors. This is due to the potential that these devices may contain a defective part that may result in

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Low FODMAP diet helps in IBS, endometriosis
Next New vitamin D indication suggested - and challenged

Related Posts